BioXcel Therapeutics Inc (BTAI)

Track

Stock chart
Ticker: BTAI Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-17 2024-12-16 PS Planned sale

O'Neill Vincent

See Remarks

Officer
165 -0.8%
0.35
USD 58 		165 -0.8% 0.35 USD 58
2024-12-17 2024-12-16 PS Planned sale

Yocca Frank

Chief Scientific Officer

Officer
225 -0.8%
0.35
USD 79 		225 -0.8% 0.35 USD 79
2024-12-17 2024-12-16 PS Planned sale

Yocca Frank

Chief Scientific Officer

Officer
205 -0.7%
0.36
USD 73 		205 -0.7% 0.36 USD 73
2024-12-17 2024-12-16 PS Planned sale

Mehta Vimal

CEO and President

Executive Director Large shareholder
2,134 -3.5%
0.36
USD 773 		2,134 -3.5% 0.36 USD 773
2024-12-17 2024-12-16 PS Planned sale

Mehta Vimal

CEO and President

Executive Director Large shareholder
983 -1.6%
0.36
USD 358 		983 -1.6% 0.36 USD 358
2024-12-17 2024-12-16 PS Planned sale

Rodriguez Javier

See Remarks

Officer
220 -0.9%
0.36
USD 78 		220 -0.9% 0.36 USD 78
2024-12-17 2024-12-16 PS Planned sale

Rodriguez Javier

See Remarks

Officer
210 -0.8%
0.36
USD 75 		210 -0.8% 0.36 USD 75
2024-12-17 2024-12-16 PS Planned sale

Steinhart Richard I

Chief Financial Officer

Officer
372 -1.7%
0.36
USD 133 		372 -1.7% 0.36 USD 133
2024-12-17 2024-12-16 PS Planned sale

Steinhart Richard I

Chief Financial Officer

Officer
205 -1.0%
0.36
USD 74 		205 -1.0% 0.36 USD 74
2024-10-03 2024-10-03 PS Planned sale

O'Neill Vincent

See Remarks

Officer
5,556 -22.1%
0.55
USD 3,056 		5,556 -22.1% 0.55 USD 3,056
2024-10-03 2024-10-03 PS Planned sale

Yocca Frank

Chief Scientific Officer

Officer
7,175 -20.2%
0.55
USD 3,946 		7,175 -20.2% 0.55 USD 3,946
2024-10-03 2024-10-03 PS Planned sale

Rodriguez Javier

See Remarks

Officer
6,863 -22.4%
0.55
USD 3,775 		6,863 -22.4% 0.55 USD 3,775
2024-10-03 2024-10-03 PS Planned sale

Steinhart Richard I

Chief Financial Officer

Officer
7,175 -26.1%
0.55
USD 3,946 		7,175 -26.1% 0.55 USD 3,946
2024-10-03 2024-10-03 PS Planned sale

Wiley Matthew T.

Chief Commercial Officer

Officer
6,272 -24.8%
0.55
USD 3,450 		6,272 -24.8% 0.55 USD 3,450
2024-09-17 2024-09-16 PS Planned sale

Mehta Vimal

CEO and President

Executive Director Large shareholder
1,150 -2.2%
0.69
USD 794 		1,150 -2.2% 0.69 USD 794
2024-09-17 2024-09-16 PS Planned sale

Mehta Vimal

CEO and President

Executive Director Large shareholder
832 -1.6%
0.69
USD 573 		832 -1.6% 0.69 USD 573
2024-09-17 2024-09-16 PS Planned sale

Steinhart Richard I

Chief Financial Officer

Officer
356 -5.4%
0.69
USD 246 		356 -5.4% 0.69 USD 246
2024-09-17 2024-09-16 PS Planned sale

Rodriguez Javier

See Remarks

Officer
345 -3.6%
0.69
USD 238 		345 -3.6% 0.69 USD 238
2024-09-17 2024-09-16 PS Planned sale

Wiley Matthew T.

Chief Commercial Officer

Officer
215 -5.1%
0.69
USD 149 		215 -5.1% 0.69 USD 149
2024-09-17 2024-09-16 PS Planned sale

O'Neill Vincent

See Remarks

Officer
138 -3.4%
0.69
USD 95 		138 -3.4% 0.69 USD 95
// ... existing code ...